HC upholds its earlier order on asthma drug Indamet against Glenmark Pharma
The Delhi High Court has upheld its single judge’s July order that restrained generic drug maker Glenmark Pharmaceuticals from manufacturing, selling or advertising its asthma drug under the mark Indamet or any other mark which is identical or deceptively …